Markets

Health Care Sector Update for 07/26/2016: NDRM

Top Health-care stocks:

JNJ: -0.1%

PFE: +0.2%

ABT: flat

MRK: flat

AMGN: +0.5%

Health-care shares were mixed in pre-market trade on Tuesday.

In health-care stocks news, pharmaceutical company NeuroDerm ( NDRM ) has begun dosing in its European Union bioequivalence trial comparing ND0701, the company's liquid apomorphine-base formulation, with commercial continuous, subcutaneously delivered apomorphine-HCl.

Shares in the company were flat at $17.03 pre-bell. The stock has traded between $11.76 and $26.50 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets